These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38805126)

  • 21. Pathogenic role of the gut microbiota in gastrointestinal diseases.
    Nagao-Kitamoto H; Kitamoto S; Kuffa P; Kamada N
    Intest Res; 2016 Apr; 14(2):127-38. PubMed ID: 27175113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer.
    Chambers LM; Esakov Rhoades EL; Bharti R; Braley C; Tewari S; Trestan L; Alali Z; Bayik D; Lathia JD; Sangwan N; Bazeley P; Joehlin-Price AS; Wang Z; Dutta S; Dwidar M; Hajjar A; Ahern PP; Claesen J; Rose P; Vargas R; Brown JM; Michener CM; Reizes O
    Cancer Res; 2022 Dec; 82(24):4654-4669. PubMed ID: 36206317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lupus: The microbiome angle.
    Yacoub R; Jacob A; Wlaschin J; McGregor M; Quigg RJ; Alexander JJ
    Immunobiology; 2018; 223(6-7):460-465. PubMed ID: 29478734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the gut microbiome in gastrointestinal cancers.
    Mishra Y; Ranjan A; Mishra V; Chattaraj A; Aljabali AAA; El-Tanani M; Hromić-Jahjefendić A; Uversky VN; Tambuwala MM
    Cell Signal; 2024 Mar; 115():111013. PubMed ID: 38113978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncobiome at the Forefront of a Novel Molecular Mechanism to Understand the Microbiome and Cancer.
    Astudillo-de la Vega H; Alonso-Luna O; Ali-Pérez J; López-Camarillo C; Ruiz-Garcia E
    Adv Exp Med Biol; 2019; 1168():147-156. PubMed ID: 31713170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota and female health.
    Wang MY; Sang LX; Sun SY
    World J Gastroenterol; 2024 Mar; 30(12):1655-1662. PubMed ID: 38617735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiome dysbiosis in inflammatory bowel disease.
    Lal S; Kandiyal B; Ahuja V; Takeda K; Das B
    Prog Mol Biol Transl Sci; 2022; 192(1):179-204. PubMed ID: 36280319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy.
    Cocomazzi G; Del Pup L; Contu V; Maggio G; Parmegiani L; Ciampaglia W; De Ruvo D; Faioli R; Maglione A; Baldini GM; Baldini D; Pazienza V
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ovarian cancer oncobiome.
    Banerjee S; Tian T; Wei Z; Shih N; Feldman MD; Alwine JC; Coukos G; Robertson ES
    Oncotarget; 2017 May; 8(22):36225-36245. PubMed ID: 28410234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The female reproductive tract microbiotas, inflammation, and gynecological conditions.
    Gholiof M; Adamson-De Luca E; Wessels JM
    Front Reprod Health; 2022; 4():963752. PubMed ID: 36303679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between the microbiota and women's cancers - Cause or consequences?
    Alizadehmohajer N; Shojaeifar S; Nedaeinia R; Esparvarinha M; Mohammadi F; Ferns GA; Ghayour-Mobarhan M; Manian M; Balouchi A
    Biomed Pharmacother; 2020 Jul; 127():110203. PubMed ID: 32559847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
    Fan X; Jin Y; Chen G; Ma X; Zhang L
    Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy.
    Kashyap S; Das A
    Acta Microbiol Immunol Hung; 2023 Jun; 70(2):85-99. PubMed ID: 37307215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Birth Mode Does Not Determine the Presence of Shared Bacterial Strains between the Maternal Vaginal Microbiome and the Infant Stool Microbiome.
    Dos Santos SJ; Shukla I; Hill JE; Money DM;
    Microbiol Spectr; 2023 Aug; 11(4):e0061423. PubMed ID: 37338388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbial dysbiosis and epigenetics modulation in cancer development - A chemopreventive approach.
    Haque S; Raina R; Afroze N; Hussain A; Alsulimani A; Singh V; Mishra BN; Kaul S; Kharwar RN
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):666-681. PubMed ID: 34216789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and the neonatal microbiome: will the pandemic cost infants their microbes?
    Romano-Keeler J; Zhang J; Sun J
    Gut Microbes; 2021; 13(1):1-7. PubMed ID: 33960272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.